
covid-optimized
The ongoing global pandemic has created an urgent need for rapid tests that can diagnose the presence of the SARS-CoV-2 virus, the pathogen that causes COVID-19, and distinguish it from other respiratory viruses.
No summary available for this article yet
No audio available for this article yet.
No quiz available for this article yet.
Follow us
Get Pathology News Delivered to Your Inbox
Learn More
More Stories
Editor2026-08-17T09:19:14+00:00
Open-Source Platform Brings High-Resolution Spatial Biology Within Reach of Smaller Labs
Editor2026-08-17T09:19:14+00:00August 17, 2026|
Editor2026-08-14T06:48:56+00:00
Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ
Editor2026-08-14T06:48:56+00:00August 13, 2026|
Editor2026-08-13T08:46:16+00:00
Pathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy
Editor2026-08-13T08:46:16+00:00August 13, 2026|
Editor2026-08-14T06:49:00+00:00
OnePath Diagnostic Now Runs on elea’s AI-Native Pathology Operating System
Editor2026-08-14T06:49:00+00:00August 13, 2026|
Editor2026-08-12T08:47:23+00:00
A multisite survey on patient perspectives of breast cancer risk assessment and supplemental breast cancer screening tools
Editor2026-08-12T08:47:23+00:00August 12, 2026|
Editor2026-08-10T07:51:40+00:00
Keeping Digital Pathology Open: The Regulatory Framework Behind Concentriq AP-Dx
Editor2026-08-10T07:51:40+00:00August 12, 2026|
Editor2026-08-11T14:54:03+00:00
Lumea Climbs the 2026 Inc. 5000 Ranking, Reflecting Continued Rapid Growth
Editor2026-08-11T14:54:03+00:00August 11, 2026|







